To comply with article 19 of the Regulation (EU) No 596/2014 (Market Abuse Regulation), members of the Management and Supervisory Board as well as other persons charged with managerial responsibilities and all person closely associated with the aforementioned persons shall notify the Company of each transaction with shares of SCHOTT Pharma AG & Co. KGaA and additional related financial instruments conducted on their own account if the transaction volume reaches a total amount of EUR 20,000 within a single year.

This section contains an overview of all transactions.

Date of publication Name Transaction type Financial instrument
March 04, 2024 Jens Schulte Sell Share
Date of publication Name Transaction type Financial instrument
October 05, 2023 Ann-Kristin Erkens Acquisition Share
October 05, 2023 Andreas Reisse Acquisition Share
October 05, 2023 Almuth Steinkühler Acquisition Share
October 05, 2023 Jens Schulte Acquisition Share
October 05, 2023 Wolfgang Wienand Acquisition Share
October 05, 2023 Peter Goldschmidt Acquisition Share